{
  "cik": 1649094,
  "cik_padded": "0001649094",
  "entityName": "Vaxcyte, Inc.",
  "fiscal_years": [
    {
      "accn": "0001649094-26-000007",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 13713000.0,
        "cash": 173959000.0,
        "eps_diluted": -5.63,
        "free_cash_flow": -669290000.0,
        "net_income": -766628000.0,
        "operating_cash_flow": -655577000.0,
        "operating_income": -923675000.0,
        "stockholders_equity": 2685510000.0,
        "total_assets": 3002717000.0,
        "total_liabilities": 317207000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11811797386716118,
        "roa_avg2y": -0.2353773045431902,
        "roa_period_end": -0.2553114396061967,
        "roe_avg2y": -0.2559125028854199,
        "roe_period_end": -0.2854683095575887
      }
    },
    {
      "accn": "0001649094-26-000007",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 22427000.0,
        "cash": 387878000.0,
        "eps_diluted": -3.8,
        "free_cash_flow": -475054000.0,
        "net_income": -463927000.0,
        "operating_cash_flow": -452627000.0,
        "operating_income": -569546000.0,
        "stockholders_equity": 3305819000.0,
        "total_assets": 3511318000.0,
        "total_liabilities": 205499000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06216281048659954,
        "roa_avg2y": -0.1886175391092314,
        "roa_period_end": -0.13212332235360055,
        "roe_avg2y": -0.20409050286530525,
        "roe_period_end": -0.14033647940192734
      }
    },
    {
      "accn": "0001649094-26-000007",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 16062000.0,
        "cash": 397451000.0,
        "eps_diluted": -4.14,
        "free_cash_flow": -312852000.0,
        "net_income": -402266000.0,
        "operating_cash_flow": -296790000.0,
        "operating_income": -468041000.0,
        "stockholders_equity": 1240468000.0,
        "total_assets": 1407917000.0,
        "total_liabilities": 167449000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13498856883047367,
        "roa_avg2y": -0.3332644324270586,
        "roa_period_end": -0.28571712679085487,
        "roe_avg2y": -0.3666829073311332,
        "roe_period_end": -0.32428567282670734
      }
    },
    {
      "accn": "0001649094-26-000007",
      "filed": "2026-02-24",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5841000.0,
        "cash": 834657000.0,
        "eps_diluted": -3.44,
        "free_cash_flow": -176438000.0,
        "net_income": -223485000.0,
        "operating_cash_flow": -170597000.0,
        "operating_income": -232256000.0,
        "stockholders_equity": 953613000.0,
        "total_assets": 1006178000.0,
        "total_liabilities": 52565000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05512194150037804,
        "roa_avg2y": -0.33593758807679736,
        "roa_period_end": -0.22211278720067423,
        "roe_avg2y": -0.3611496479968585,
        "roe_period_end": -0.23435607526323574
      }
    },
    {
      "accn": "0001649094-25-000028",
      "filed": "2025-02-25",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6555000.0,
        "cash": 68985000.0,
        "eps_diluted": -1.93,
        "free_cash_flow": -127948000.0,
        "net_income": -100077000.0,
        "operating_cash_flow": -121393000.0,
        "operating_income": -103670000.0,
        "stockholders_equity": 284018000.0,
        "total_assets": 324337000.0,
        "total_liabilities": 40319000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14195931243794407,
        "roa_avg2y": -0.27909136416686303,
        "roa_period_end": -0.3085586904978464,
        "roe_avg2y": -0.3177748741388973,
        "roe_period_end": -0.35236147004767304
      }
    },
    {
      "accn": "0000950170-24-021145",
      "filed": "2024-02-27",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1155000.0,
        "cash": 386200000.0,
        "eps_diluted": -3.02,
        "free_cash_flow": -47783000.0,
        "net_income": -89217000.0,
        "operating_cash_flow": -46628000.0,
        "operating_income": -89581000.0,
        "stockholders_equity": 345843000.0,
        "total_assets": 392826000.0,
        "total_liabilities": 46983000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1358506605598494,
        "roa_avg2y": -0.3891486596121468,
        "roa_period_end": -0.2271158222724565,
        "roe_avg2y": -0.7451204743809245,
        "roe_period_end": -0.2579696567517631
      }
    },
    {
      "accn": "0000950170-23-004654",
      "filed": "2023-02-27",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1195000.0,
        "cash": 58976000.0,
        "free_cash_flow": -48340000.0,
        "net_income": -50274000.0,
        "operating_cash_flow": -47145000.0,
        "operating_income": -54153000.0,
        "stockholders_equity": -106373000.0,
        "total_assets": 65698000.0,
        "total_liabilities": 11761000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.7652287740874912,
        "roe_avg2y": 0.6127202149895491
      }
    },
    {
      "accn": "0000950170-22-002281",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 1774000.0,
        "free_cash_flow": -32240000.0,
        "net_income": -29485000.0,
        "operating_cash_flow": -30466000.0,
        "operating_income": -35533000.0,
        "stockholders_equity": -57728000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.6789242211425545
      }
    },
    {
      "accn": "0001564590-21-016110",
      "filed": "2021-03-29",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -29130000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001649094-26-000007",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001649094.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001649094.json"
  },
  "ticker": "PCVX"
}